CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India CytoSorbents and Converge Biotech Partner In India to Expand CytoSorb Blood Purification Availability to Treat Sepsis and Other Deadly Conditions

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients CytoSorb Blood Purification Results in Significant Decrease in Organ Failure and Dysfunction in Groundbreaking Heart Transplant Randomized Controlled Trial

Organ Care Products Market Size Worth $272.16 Mn, Globally, by 2028 at 15.6% CAGR - Exclusive Report by The Insight Partners New York, March 29, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Organ Care Products Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality...